These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15314638)

  • 1. Ablation of canine prostate using two-stage intraprostatic hot agarose solution and enzyme injection.
    Zhang C; Wang LL; Shong C; Li W; Cheng XY; Jing HM
    Prostate Cancer Prostatic Dis; 2004; 7(4):316-20. PubMed ID: 15314638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral enzymatic ablation of the prostate: canine model.
    Harmon WJ; Barrett DM; Qian J; Lauvetz RW; Bostwick DG; Gocken M
    Urology; 1996 Aug; 48(2):229-33. PubMed ID: 8753734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection.
    Zvara P; Karpman E; Stoppacher R; Esenler AC; Plante MK
    Urology; 1999 Sep; 54(3):411-5. PubMed ID: 10475344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid, and pathology correlations.
    Crone JK; Burnett AL; Chamness SL; Strandberg JD; Chang TS
    J Androl; 1998; 19(3):358-64. PubMed ID: 9639053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP].
    Wang H; Chen ZH; Zhu YY; Wang T; Wu XJ
    Zhonghua Nan Ke Xue; 2006 Jun; 12(6):490-5. PubMed ID: 16833184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatment.
    Corica AG; Qian J; Ma J; Sagaz AA; Corica AP; Bostwick DG
    J Urol; 2003 Sep; 170(3):874-8. PubMed ID: 12913720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical destruction of the prostate by Prostalyser-1 and Prostalyser-2 solutions: an experimental study in dogs].
    Shioshvili TI; Chokhonelidze GZ; Shulaia TsA; Kazaishvili ED; Gogoladze TV
    Urologiia; 2005; (6):18-23. PubMed ID: 16419475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study.
    Jeon GS; Won JH; Lee BM; Kim JH; Ahn HS; Lee EJ; Park SI; Park SW
    J Vasc Interv Radiol; 2009 Mar; 20(3):384-90. PubMed ID: 19157906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer.
    Kassouf W; Brown GA; Shetty A; Hazle JD; Stafford RJ; Rosser CJ; Stephens C; Tinkey PT; Pisters LL
    Urology; 2007 Oct; 70(4):822-5. PubMed ID: 17991580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to therapy of the "prostate syndrome" in aged dogs].
    Bilkei G; Biro O; Takacs T; Kotai I; Szenci O; Goos T
    Berl Munch Tierarztl Wochenschr; 1997 Jun; 110(6):220-2. PubMed ID: 9290046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pathological change of rats' benign hyperplastic prostate after radical denervation].
    Cai JL; Xin DQ; He Q; Tang XQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):960-3. PubMed ID: 17961380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Masuda S; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
    Tokai J Exp Clin Med; 1998 Nov; 23(5):245-8. PubMed ID: 10418729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraprostatic injection of 96% ethanol in experimental animal model].
    Martov AG; Pavlov DA; Kirpatovskiĭ VI; Kudriavtsev IuV
    Urologiia; 2004; (6):21-6. PubMed ID: 15719725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A noninvasive technique for monitoring changes in canine prostatic size in vivo.
    Wade DR; Pirmann JC; Winter ML; Falvo RE
    Invest Urol; 1981 Jan; 18(4):266-9. PubMed ID: 6161103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral microwave thermotherapy effectiveness in small prostates.
    Larson BT; Mynderse L; Ulchaker J; Pulling C; Larson TR
    Urology; 2006 Oct; 68(4):790-4. PubMed ID: 17070354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.
    Noa M; Arruzazabala ML; Carbajal D; Más R; Molina V
    Int J Tissue React; 2005; 27(4):203-11. PubMed ID: 16440586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible long-term toxicity of epristeride in beagle dogs.
    Sun ZY; Feng J; Qi XD; Wu HY; Zheng WJ; Tu ZH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):145-52. PubMed ID: 9925798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.